Company Filing History:
Years Active: 2020-2025
Title: Lisbeth Helmgaard: Innovator in Ovarian Stimulation
Introduction
Lisbeth Helmgaard is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of reproductive medicine, particularly in the area of ovarian stimulation. With a total of 4 patents to her name, Helmgaard's work focuses on improving treatment options for infertility.
Latest Patents
Among her latest patents is a groundbreaking method titled "Compositions and methods for controlled ovarian stimulation." This patent describes methods and compositions that include FSH (Follicle Stimulating Hormone) for treating infertility. The innovative aspect of this method is that the dosage is tailored based on the patient's age, optimizing cumulative efficiency while reducing the risk of Ovarian Hyperstimulation Syndrome (OHSS). Another notable patent is for a "Recombinant FSH composition for controlled ovarian stimulation." This preparation includes recombinant FSH and is designed for patients with high AMH (Anti-Müllerian Hormone) levels and low body weight, providing a targeted approach to infertility treatment.
Career Highlights
Lisbeth Helmgaard is associated with Ferring B.V., a company known for its commitment to advancing reproductive health. Her work at Ferring has allowed her to focus on developing innovative solutions that address the complexities of infertility treatments.
Collaborations
Throughout her career, Helmgaard has collaborated with esteemed colleagues such as Bjarke Mirner Klein and Joan Carles Arce Saez. These collaborations have further enriched her research and development efforts in the field.
Conclusion
Lisbeth Helmgaard's contributions to reproductive medicine through her patents and work at Ferring B.V. highlight her dedication to improving infertility treatments. Her innovative approaches continue to pave the way for advancements in this critical area of healthcare.